Tiratricol
MCT8-2019-2
Phase 2 small_molecule active
Quick answer
Tiratricol for Allan-Herndon-Dudley Syndrome is a Phase 2 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Allan-Herndon-Dudley Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active